Pubmed Latest “HDL’s Antidiabetic Actions in Pancreatic β-Cells: Role of Ecto-F(1)-ATPase” by satcit 23 December 2023 written by satcit 23 December 2023 67 https://pubmed.ncbi.nlm.nih.gov/38095108 This study suggests that HDL’s antidiabetic actions in pancreatic β-cells may involve a new player, Ecto-F(1)-ATPase. 0 comment 0 FacebookTwitterPinterestLinkedinTumblrRedditWhatsappTelegramEmail satcit previous post “Deep Learning Accelerates Genomics and Machine Learning for Aortic Disease Therapeutic Targets Identification and Biological Insight Translation” next post “Rapid Weight Loss and Mortality in Older Women with Abdominal Aortic Calcification” You may also like “Addressing Modifiable Risk Factors to Improve Cardiovascular Outcomes:... 8 January 2024 “Modifiable Risk Factors’ Impact on Cardiovascular Outcomes: A... 8 January 2024 “Semaglutide May Improve Heart Failure in Obese Patients... 8 January 2024 Semaglutide’s Potential Beneficial Effects on Heart Failure with... 8 January 2024 “Semaglutide May Lower Heart Failure Hospitalization Risk in... 8 January 2024 “Semaglutide May Reduce Cardiovascular Risks in Heart Failure... 8 January 2024 “Methemoglobinemia Outbreak in Japanese Neonatal ICU and Maternity... 8 January 2024 “New Perspectives on Medical Ethics: A Commentary in... 8 January 2024 “Balancing Probability and Precision in Designing Future ARDS... 8 January 2024 “Evaluating Doxycycline Postexposure Prophylaxis for Preventing Sexually Transmitted... 8 January 2024 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.